<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="25/08/2006" creator="Yo Shidahara" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8903467"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8903467</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><cons sem="(AND Cell_natural Cell_natural)" id="T1" lex="(AND Nasal_NK-cell_lymphoma T-cell_lymphoma)"><frag id="F1">Nasal NK-</frag> and <frag id="F2">T-cell</frag> <frag id="F3">lymphomas</frag></cons> share the same type of <term sem="Other" id="T2" lex="Epstein-Barr_virus_latency"><term sem="Virus" id="T3" lex="Epstein-Barr_virus">Epstein-Barr virus</term> latency</term> as <term sem="Tissue_natural" id="T4" lex="nasopharyngeal_carcinoma">nasopharyngeal carcinoma</term> and <term sem="Other" id="T5" lex="Hodgkin&apos;s_disease">Hodgkin&apos;s disease</term>.</sentence>
<event id="E101">
<type class="Viral_life_cycle" />
<theme idref="T3" />
<clue><clueLoc>Nasal NK-</clueLoc> and T-<clueLoc>cell lymphomas</clueLoc> share the same type of Epstein-Barr virus <clueType>latency</clueType> as nasopharyngeal carcinoma and Hodgkin&apos;s disease.</clue>
</event>
<event id="E201">
<type class="Viral_life_cycle" />
<theme idref="T3" />
<clue>Nasal NK- and <clueLoc>T-cell lymphomas</clueLoc> share the same type of Epstein-Barr virus <clueType>latency</clueType> as nasopharyngeal carcinoma and Hodgkin&apos;s disease.</clue>
</event>
<event id="E102">
<type class="Viral_life_cycle" />
<theme idref="T3" />
<clue>Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus <clueType>latency</clueType> as <clueLoc>nasopharyngeal carcinoma</clueLoc> and Hodgkin&apos;s disease.</clue>
</event>
<event id="E202">
<type class="Viral_life_cycle" />
<theme idref="T3" />
<clue>Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus <clueType>latency</clueType> as nasopharyngeal carcinoma and <clueLoc>Hodgkin&apos;s disease</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Cell_natural" id="T6" lex="nasal_T/NK-cell_lymphoma">Nasal T/NK-cell lymphomas</term> can be further separated into those of <term sem="Cell_natural" id="T7" lex="natural_killer_(NK)_cell_lineage">natural killer (NK) cell lineage</term> or of <term sem="Cell_natural" id="T8" lex="T-cell_lineage">T-cell lineage</term>, with differences in cellular phenotype, <term sem="Other" id="T9" lex="T-cell_receptor_(TcR)_gene_rearrangement"><term sem="DNA_domain_or_region" id="T10" lex="T-cell_receptor_(TcR)_gene"><term sem="Protein_family_or_group" id="T11" lex="T-cell_receptor">T-cell receptor</term> (TcR) gene</term> rearrangement</term> and <term sem="RNA_molecule" id="A1">TcR transcript</term> expression.</sentence>
<event id="E1">
<type class="DNA_recombination" />
<theme idref="T10" />
<clue>Nasal T/NK-cell lymphomas can be further separated into those of <clueLoc>natural killer (NK) cell lineage</clueLoc> or of <clueLoc>T-cell lineage</clueLoc>, with differences in cellular phenotype, T-cell receptor (TcR) gene <clueType>rearrangement</clueType> and TcR transcript expression.</clue>
</event>
<event id="E2">
<type class="Transcription" />
<theme idref="A1" />
<clue>Nasal T/NK-cell lymphomas can be further separated into those of <clueLoc>natural killer (NK) cell lineage</clueLoc> or of <clueLoc>T-cell lineage</clueLoc>, with differences in cellular phenotype, T-cell receptor (TcR) gene rearrangement and TcR transcript <clueType>expression</clueType>.</clue>
</event>
<sentence id="S3">Both <cons sem="(AND Cell_natural Cell_natural)" id="T12" lex="(AND NK-cell_subtype T-cell_subtype)"><frag id="F4">NK-</frag> and <frag id="F5">T-cell</frag> <frag id="F6">subtypes</frag></cons> are closely associated with <term sem="Virus" id="T13" lex="Epstein-Barr_virus">Epstein-Barr virus</term> (<term sem="Virus" id="T14" lex="EBV">EBV</term>).</sentence>
<sentence id="S4">In this study, <term sem="Other" id="T15" lex="EBV_gene_expression"><term sem="DNA_family_or_group" id="T16" lex="EBV_gene"><term sem="Virus" id="T17" lex="EBV">EBV</term> gene</term> expression</term> was determined in 23 cases of <term sem="Tissue_natural" id="T18" lex="nasal_lymphoma">nasal lymphoma</term> (<term sem="Tissue_natural" id="T19" lex="NL">NL</term>) by <term sem="Other" id="T20" lex="in_situ_hybridisation">in situ hybridisation</term> (<term sem="Other" id="T21" lex="ISH">ISH</term>), <term sem="Other" id="T22" lex="reverse_transcriptase-polymerase_chain_reaction"><term sem="Protein_molecule" id="T23" lex="reverse_transcriptase">reverse transcriptase</term>-polymerase chain reaction</term> (<term sem="Other" id="T24" lex="RT-PCR">RT-PCR</term>) and <term sem="Other" id="T25" lex="immunohistochemistry">immunohistochemistry</term> (<term sem="Other" id="T26" lex="IH">IH</term>).</sentence>
<event uncertainty="doubtful" id="E3">
<type class="Gene_expression" />
<theme idref="T16" />
<clue>In this study, EBV gene <clueType>expression</clueType> was determined <clueLoc>in 23 cases of nasal lymphoma (NL)</clueLoc> <clueExperiment>by in situ hybridisation (ISH)</clueExperiment>, <clueExperiment>reverse transcriptase-polymerase chain reaction (RT-PCR)</clueExperiment> and <clueExperiment>immunohistochemistry (IH)</clueExperiment>.</clue>
</event>
<sentence id="S5">Of the 23 cases, 19 were classified as <term sem="Tissue_natural" id="T27" lex="NK-cell_tumor">NK-cell</term> and 4 as <term sem="Tissue_natural" id="T28" lex="T-cell_tumour">T-cell tumours</term>.</sentence>
<sentence id="S6"><term sem="Other" id="T29" lex="ISH">ISH</term> for <term sem="RNA_family_or_group" id="T30" lex="EBV-encoded_small_non-polyadenylated_RNA"><term sem="Virus" id="T31" lex="EBV">EBV</term>-encoded small non-polyadenylated RNAs</term> showed that all cases, whether NK or T, harboured <term sem="Virus" id="T32" lex="EBV">EBV</term> in virtually all <term sem="Cell_natural" id="T33" lex="tumour_cell">tumour cells</term>.</sentence>
<sentence id="S7"><term sem="Other" id="T34" lex="RT-PCR">RT-PCR</term> demonstrated that <term sem="Cell_natural" id="T35" lex="NL">NL</term> of both subtypes expressed <term sem="Protein_molecule" id="T36" lex="EBNAI">EBNAI</term> of the <term sem="Other" id="T37" lex="QUK_splice_pattern">QUK splice pattern</term>, the <term sem="Protein_family_or_group" id="T38" lex="latent_membrane_protein">latent membrane proteins</term>, <cons sem="(AND Protein_molecule Protein_molecule)" id="T39" lex="(AND LMP1 LMP2)"><frag id="F7"><term sem="Protein_molecule" id="A2">LMP</term></frag><frag id="F8"><term sem="Protein_molecule" id="A3">1</term></frag> and <frag id="F9"><term sem="Protein_molecule" id="A4">2</term></frag></cons> and the <term sem="RNA_family_or_group" id="T40" lex="BamHI_A_rightward_transcript">BamHI A rightward transcripts</term> in the absence of <term sem="RNA_family_or_group" id="T41" lex="EBNA2_mRNA">EBNA2 mRNAs</term>, compatible with the <term sem="Other" id="T42" lex="latency_type_II_pattern">latency type II pattern</term>.</sentence>
<event id="E4">
<type class="Gene_expression" />
<theme idref="T36" />
<clue><clueExperiment>RT-PCR</clueExperiment> demonstrated that <clueLoc>NL of both subtypes</clueLoc> <clueType>expressed</clueType> EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<event id="E5">
<type class="Gene_expression" />
<theme idref1="A3" idref="A2" />
<clue><clueExperiment>RT-PCR</clueExperiment> demonstrated that <clueLoc>NL of both subtypes</clueLoc> <clueType>expressed</clueType> EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<event id="E6">
<type class="Gene_expression" />
<theme idref1="A4" idref="A2" />
<clue><clueExperiment>RT-PCR</clueExperiment> demonstrated that <clueLoc>NL of both subtypes</clueLoc> <clueType>expressed</clueType> EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<event id="E7">
<type class="Transcription" />
<theme idref="T40" />
<clue><clueExperiment>RT-PCR</clueExperiment> demonstrated that <clueLoc>NL of both subtypes</clueLoc> <clueType>expressed</clueType> EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<event assertion="non-exist" id="E8">
<type class="Transcription" />
<theme idref="T41" />
<clue><clueExperiment>RT-PCR</clueExperiment> demonstrated that <clueLoc>NL of both subtypes</clueLoc> expressed EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the <clueType>absence</clueType> <linkTheme>of</linkTheme> EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<sentence id="S8">In addition, analysis of <term sem="Other" id="T43" lex="EBV_protein_expression"><term sem="Protein_family_or_group" id="A5"><term sem="Virus" id="T44" lex="EBV">EBV</term> protein</term> expression</term> by <term sem="Other" id="T45" lex="IH">IH</term> revealed a heterogeneous pattern of <term sem="Other" id="T46" lex="EBV_gene_expression"><term sem="DNA_family_or_group" id="T47" lex="EBV_gene"><term sem="Virus" id="T48" lex="EBV">EBV</term> gene</term> expression</term> at the single-cell level consisting of both <cons sem="(AND Cell_natural Cell_natural)" id="T49" lex="(AND LMP1+_tumour_cell LMP1-_tumour_cell)"><frag id="F10">LMP1+</frag> and <frag id="F11">LMP1-</frag> <frag id="F12">tumour cells</frag></cons>, suggesting a mixture of <cons sem="(AND Other Other)" id="C1" lex="(AND latency_I latency_II)"><frag id="F13">latency</frag> <frag id="F14">I</frag> and <frag id="F15">II</frag></cons>.</sentence>
<event uncertainty="doubtful" id="E9">
<type class="Gene_expression" />
<theme idref="A5" />
<clue>In addition, analysis of EBV protein <clueType>expression</clueType> by IH revealed a heterogeneous pattern of EBV gene expression at the single-cell level consisting of both LMP1+ and LMP1- tumour cells, suggesting a mixture of latency I and II.</clue>
</event>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T47" />
<clue>In addition, analysis of EBV protein expression <clueExperiment>by IH</clueExperiment> revealed a heterogeneous pattern of EBV gene <clueType>expression</clueType> at the single-cell level consisting of both <clueLoc>LMP1+</clueLoc> and LMP1- <clueLoc>tumour cells</clueLoc>, suggesting a mixture of latency I and II.</clue>
</event>
<event id="E110">
<type class="Gene_expression" />
<theme idref="T47" />
<clue>In addition, analysis of EBV protein expression <clueExperiment>by IH</clueExperiment> revealed a heterogeneous pattern of EBV gene <clueType>expression</clueType> at the single-cell level consisting of both LMP1+ and <clueLoc>LMP1- tumour cells</clueLoc>, suggesting a mixture of latency I and II.</clue>
</event>
<sentence id="S9">Although 2 <term sem="Protein_family_or_group" id="T51" lex="early_lytic_transcript">early lytic transcripts</term>, <term sem="Protein_molecule" id="T52" lex="BZLF1">BZLF1</term> and <term sem="Protein_molecule" id="T53" lex="BHRF1">BHRF1</term>, were also detected in 13 and 10 cases, respectively, the lack of <term sem="Other" id="T54" lex="ZEBRA_staining"><term sem="Protein_molecule" id="T55" lex="ZEBRA">ZEBRA</term> staining</term> in any case indicates that these lytic transcripts are most likely expressed by rare <term sem="Cell_natural" id="A6">cells</term> in the biopsies entering lytic cycle.</sentence>
<event id="E11">
<type class="Gene_expression" />
<theme idref="T52" />
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also <clueType>detected</clueType> <clueLoc>in 13</clueLoc> and 10 <clueLoc>cases</clueLoc>, respectively, the lack of ZEBRA staining in any case indicates that these lytic transcripts are most likely expressed by rare cells in the biopsies entering lytic cycle.</clue>
</event>
<event id="E12">
<type class="Gene_expression" />
<theme idref="T53" />
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also <clueType>detected</clueType> <clueLoc>in</clueLoc> 13 and <clueLoc>10 cases</clueLoc>, respectively, the lack of ZEBRA staining in any case indicates that these lytic transcripts are most likely expressed by rare cells in the biopsies entering lytic cycle.</clue>
</event>
<event assertion="non-exist" id="E13">
<type class="Gene_expression" />
<theme idref="T55" />
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also detected in 13 and 10 cases, respectively, the <clueType>lack</clueType> <linkTheme>of</linkTheme> ZEBRA staining <clueLoc>in any case</clueLoc> indicates that these lytic transcripts are most likely expressed by rare cells in the biopsies entering lytic cycle.</clue>
</event>
<event id="E14">
<type class="Viral_life_cycle" />
<theme idref="A6" />
<cause idref="T44" />
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also detected in 13 and 10 cases, respectively, the lack of ZEBRA staining in any case indicates that these lytic transcripts are most likely expressed by rare cells in the biopsies <clueType>entering lytic cycle</clueType>.</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E15">
<type class="Gene_expression" />
<theme idref="T52" />
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also detected in 13 and 10 cases, respectively, the lack of ZEBRA staining in any case indicates that <corefTheme>these lytic transcripts</corefTheme> are most likely <clueType>expressed</clueType> <clueLoc>by rare cells in the biopsies entering lytic cycle</clueLoc>.</clue>
</event>
<event id="E16">
<type class="Gene_expression" />
<theme idref="T53" />
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also detected in 13 and 10 cases, respectively, the lack of ZEBRA staining in any case indicates that <corefTheme>these lytic transcripts</corefTheme> are most likely <clueType>expressed</clueType> <clueLoc>by rare cells in the biopsies entering lytic cycle</clueLoc>.</clue>
</event>
<sentence id="S10">The <term sem="Other" id="T56" lex="viral_transcriptional_pattern">viral transcriptional pattern</term> similar to that of <term sem="Tissue_natural" id="T57" lex="nasopharyngeal_carcinoma">nasopharyngeal carcinoma</term> and <term sem="Other" id="T58" lex="Hodgkin&apos;s_disease">Hodgkin&apos;s disease</term> suggests that <term sem="Virus" id="T59" lex="EBV">EBV</term> can exploit <term sem="Other" id="A101"><term sem="Other" id="T60" lex="common_regulatory_mechanism">common regulatory mechanisms</term> for <term sem="Other" id="T61" lex="gene_transcription"><term sem="DNA_domain_or_region" id="A21">gene</term> transcription</term></term> in diverse host cell types.</sentence>
<event id="E17">
<type class="Transcription" />
<theme idref="T59" />
<clue><corefTheme>The viral</corefTheme> <clueType>transcriptional pattern</clueType> similar to that of nasopharyngeal carcinoma and Hodgkin&apos;s disease suggests that EBV can exploit common regulatory mechanisms for gene transcription in diverse host cell types.</clue>
</event>
<event id="E18">
<type class="Transcription" />
<theme idref="A21" />
<clue>The viral transcriptional pattern similar to that of nasopharyngeal carcinoma and Hodgkin&apos;s disease suggests that EBV can exploit common regulatory mechanisms for gene <clueType>transcription</clueType> in diverse host cell types.</clue>
</event>
<event id="E19">
<type class="Regulation" />
<theme idref="E18" />
<clue>The viral transcriptional pattern similar to that of nasopharyngeal carcinoma and Hodgkin&apos;s disease suggests that EBV can exploit common <clueType>regulatory mechanisms</clueType> <linkTheme>for</linkTheme> gene transcription <clueLoc>in diverse host cell types</clueLoc>.</clue>
</event>
<event id="E20">
<type class="Regulation" />
<theme idref="T59" />
<cause idref="A101" />
<clue>The viral transcriptional pattern similar to that of nasopharyngeal carcinoma and Hodgkin&apos;s disease suggests that EBV can <clueType>exploit</clueType> common regulatory mechanisms for gene transcription <clueLoc>in diverse host cell types</clueLoc>.</clue>
<comment>TPS A101</comment></event>
<sentence id="S11">Down-regulation of <term sem="Protein_family_or_group" id="T62" lex="immunogenic_protein">immunogenic proteins</term> (<term sem="Protein_family_or_group" id="T63" lex="EBNA2-EBNA6"><term sem="Protein_molecule" id="A22">EBNA2</term>-<term sem="Protein_molecule" id="A23">EBNA6</term></term>) in <term sem="Tissue_natural" id="A25">nasal lymphoma</term> may enable <term sem="Cell_natural" id="T64" lex="tumour_cell">tumour cells</term> to evade host <term sem="Other" id="T65" lex="cytotoxic_T-cell_surveillance"><term sem="Cell_natural" id="A24">cytotoxic T-cell</term> surveillance</term>.</sentence>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="A22" />
<clue><clueType>Down-regulation</clueType> <linkTheme>of</linkTheme> immunogenic proteins (EBNA2-EBNA6) <clueLoc>in nasal lymphoma</clueLoc> may enable tumour cells to evade host cytotoxic T-cell surveillance.</clue>
<comment>CAUTION: EBNA2-EBNA6 includes EBNA3, EBNA4 and EBNA5</comment></event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="A23" />
<clue><clueType>Down-regulation</clueType> <linkTheme>of</linkTheme> immunogenic proteins (EBNA2-EBNA6) <clueLoc>in nasal lymphoma</clueLoc> may enable tumour cells to evade host cytotoxic T-cell surveillance.</clue>
</event>
<event id="E23">
<type class="Cell_recognition" />
<theme idref="T64" />
<theme idref="A24" />
<clue>Down-regulation of immunogenic proteins (EBNA2-EBNA6) in nasal lymphoma may enable tumour cells to evade host cytotoxic T-cell <clueType>surveillance</clueType>.</clue>
</event>
<event id="E24">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E21" />
<clue>Down-regulation of immunogenic proteins (EBNA2-EBNA6) in nasal lymphoma may <clueType>enable</clueType> tumour cells <clueType>to evade</clueType> host cytotoxic T-cell surveillance.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E22" />
<clue>Down-regulation of immunogenic proteins (EBNA2-EBNA6) in nasal lymphoma may <clueType>enable</clueType> tumour cells <clueType>to evade</clueType> host cytotoxic T-cell surveillance.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
